Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a.

Slides:

Advertisements

Similar presentations

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Advertisements

Richard M. Green, MD, William M

A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia–associated.

James C. Harms, MD, Sunil Rangarajan, MD, Carlton J

Peter J. Fahner, MD, Mirza M. Idu, MD, PhD, Thomas M

Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair Fran Parkinson, MB BCh, Stuart Ferguson, MB BChir,

Flow measurement before and after papaverine injection in above-knee prosthetic femoropopliteal bypass Gustav Pedersen, MD, Elin Laxdal, MD, Svein Roar.

Andrew H. Stewart, FRCS, Paul S. Eyers, FRCS, Jonothan J

Howard E. Katzman, MD, Robert B. McLafferty, MD, John R

The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery Jasper van der Slegt, MD, Stijn L. Steunenberg,

A new valvulotome for in situ bypass grafts

Vein harvesting technique for infrainguinal arterial bypass with great saphenous vein and its association with surgical site infection and graft patency

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery Scott M. Damrauer, MD, Ann C. Gaffey, MD, Ann.

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

Michael J. Singh, MD, Ronald Fairman, MD, Paul Anain, MD, William D

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Essentials of negotiating for employment in a changing environment

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Axillopopliteal bypass for limb salvage

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Infrainguinal revascularizations in octogenarians and septuagenarians

A meta-analysis of dialysis access outcome in elderly patients

Thrombolysis for lower extremity bypass graft occlusion

Cryopreserved saphenous vein graft in infrainguinal bypass

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Five-Year Patency Rates for Heparin-Bonded Expanded Polytetrafluoroethylene Femoropopliteal Bypass Grafts vs ePTFE Grafts Without Heparin Russell H.

Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access Isibor Arhuidese, MD, MPH, Thomas Reifsnyder,

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

Marvin V. Weaver, MD, Rami O. Tadros, MD, Varinder S

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia

Journal of Vascular Surgery

Abd Moain Abu Dabrh, MBBCh, MS, Mark W

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease Shant M. Vartanian, MD, Paul C. Johnston, MD, Joy.

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass Afshin Assadian, MD, Hans-Henning Eckstein, MD Afshin Assadian, MD, Felix Härtl,

A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical.

Ryan M. Svoboda, Kristina A. Giles, Samantha A. Connell, Daniel B

Simple renal cyst and abdominal aortic aneurysm

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Juxtarenal aortic aneurysm repair

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

Antonio V. Sterpetti, M. D. , Richard D. Schultz, M. D. , Richard J

Jon S. Matsumura, MD, Adnan Z. Rizvi, MD Journal of Vascular Surgery

Soma Brahmanandam, MD, MPH, Eric L. Ding, ScD, Michael S

Reviewer Acknowledgment

Philip P. Goodney, MD, MS, Adam W. Beck, MD, Jan Nagle, MS, RPh, H

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency Carlos Eduardo Pereira, MD, Maximiano Albers, MD, PhD, Marcello.

Using the diamond intermediate anastomosis in composite sequential bypass grafting for critical limb ischemia Ailín C. Rogers, PhD, Paul W. Reddy, MBBCh.

Charles S. Joels, MD, John W. York, MD, Corey A. Kalbaugh, MS, David L

Journal of Vascular Surgery

Composite sequential bypasses to the ankle and beyond for limb salvage

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Compromised bypass graft outcomes after minimal-incision vein harvest

Regarding “Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results” John B. Chang, MD,

M. Chris Pastor, MD, MSc, David Kopriva, MDCM, FRCS(C)

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

Luke S. Erdoes, MD, Timothy P. Milner, MD Journal of Vascular Surgery

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison Russell H. Samson, MD, Ricardo Morales, PA, David P. Showalter, MD, Michael R. Lepore, MD, Deepak G. Nair, MD Journal of Vascular Surgery Volume 64, Issue 3, Pages 638-647 (September 2016) DOI: 10.1016/j.jvs.2016.03.414 Copyright © 2016 Terms and Conditions

Fig 1 Propaten vs standard femoropopliteal grafts: —, Propaten; ---, standard expanded polytetrafluoroethylene (ePTFE). CI, Confidence interval. Journal of Vascular Surgery 2016 64, 638-647DOI: (10.1016/j.jvs.2016.03.414) Copyright © 2016 Terms and Conditions

Fig 2 Propaten vs standard above-knee (AK) femoropopliteal grafts: —, Propaten; ---, standard expanded polytetrafluoroethylene (ePTFE). CI, Confidence interval. Journal of Vascular Surgery 2016 64, 638-647DOI: (10.1016/j.jvs.2016.03.414) Copyright © 2016 Terms and Conditions

Fig 3 Propaten vs standard below-knee (BK) femoropopliteal grafts: —, Propaten; ---, standard expanded polytetrafluoroethylene (ePTFE). CI, Confidence interval. Journal of Vascular Surgery 2016 64, 638-647DOI: (10.1016/j.jvs.2016.03.414) Copyright © 2016 Terms and Conditions

Fig 4 Clopidogrel effect for all femoropoliteal grafts: —, No clopidogrel/aspirin; ---, clopidogrel. CI, Confidence interval. Journal of Vascular Surgery 2016 64, 638-647DOI: (10.1016/j.jvs.2016.03.414) Copyright © 2016 Terms and Conditions

Fig 5 Clopidogrel effect for Propaten femoropoliteal grafts: —, No clopidogrel/aspirin; ---, clopidogrel. CI, Confidence interval. Journal of Vascular Surgery 2016 64, 638-647DOI: (10.1016/j.jvs.2016.03.414) Copyright © 2016 Terms and Conditions

Fig 6 Forest plot of hazard ratios of variables associated with time to loss of patency in Propaten and standard grafts. The size of the blackened square is proportional to the number of patients presenting with the indicated variable. Journal of Vascular Surgery 2016 64, 638-647DOI: (10.1016/j.jvs.2016.03.414) Copyright © 2016 Terms and Conditions